![](/img/cover-not-exists.png)
6551 POSTER Efficacy and safety of single-agent axitinib (AG-013736; AG) in patients (pts) with advanced non-small cell lung cancer (NSCLC): a phase II trial
von Pawel, J., Larson, T., Ou, S.I., Limentani, S.A., Sandler, A.B., Vokes, E.E., Kim, S., Liau, K.F., Bycott, P.W., Schiller, J.H.Volume:
5
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71379-4
Date:
September, 2007
File:
PDF, 61 KB
english, 2007